4//SEC Filing
Wellisch Alejandro D 4
Accession 0001415889-23-003074
CIK 0000001800other
Filed
Feb 21, 7:00 PM ET
Accepted
Feb 22, 7:25 PM ET
Size
5.5 KB
Accession
0001415889-23-003074
Insider Transaction Report
Form 4
Wellisch Alejandro D
Senior Vice President
Transactions
- Award
Option (right to buy)
2023-02-17+31,236→ 31,236 totalExercise: $106.24From: 2024-02-17Exp: 2033-02-16→ Common Shares (31,236 underlying)
Footnotes (1)
- [F1]Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 10,412 on February 17, 2024, 10,412 on February 17, 2025, and 10,412 on February 17, 2026.
Documents
Issuer
ABBOTT LABORATORIES
CIK 0000001800
Entity typeother
Related Parties
1- filerCIK 0001717526
Filing Metadata
- Form type
- 4
- Filed
- Feb 21, 7:00 PM ET
- Accepted
- Feb 22, 7:25 PM ET
- Size
- 5.5 KB